Large Pore-Sized Hollow Mesoporous Organosilica for Redox-Responsive Gene Delivery and Synergistic Cancer Chemotherapy

Adv Mater. 2016 Mar 9;28(10):1963-9. doi: 10.1002/adma.201505524. Epub 2016 Jan 7.

Abstract

A stability-difference-selective bond-breakage strategy for the fabrication of largepore-sized hollow mesoporous organosilica nanoparticles (HMONs) is successfully developed. Moreover, surfacefunctionalized HMONs are successfully constructed to simultaneously deliver P-gp modulator siRNA and anticancer drug doxorubicin to reverse the multidrug resistance of cancer cells.

Keywords: cancer therapy; gene delivery; large pores; multidrug resistance; nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloys / chemistry
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use
  • Catalysis
  • Drug Carriers / chemistry*
  • Gene Transfer Techniques*
  • Humans
  • Metals / chemistry
  • Nanotubes / chemistry
  • Neoplasms / drug therapy
  • Oxidation-Reduction
  • Oxides / chemistry
  • Photoelectron Spectroscopy
  • Porosity
  • Silicon Dioxide / chemistry*

Substances

  • Alloys
  • Antineoplastic Agents
  • Drug Carriers
  • Metals
  • Oxides
  • Silicon Dioxide